首页--医药、卫生论文--肿瘤学论文--呼吸系肿瘤论文--肺肿瘤论文

Aptamer-Mediated and Multifaceted Approach to Detect and Combat Lung Cancer

Abstract第6-7页
1. Introduction第10-12页
2. Iron Oxide Nanoparticle Mediated Gene Therapy with Aptamer Guidance第12-35页
    2.1 Background第12-14页
    2.2 Design第14-18页
    2.3 Materials and Methods第18-22页
        2.3.1 Materials第18页
        2.3.2 Cell Culture第18页
        2.3.3 Oligonucleotide Synthesis第18-19页
        2.3.4 Oligonucleotide Purification第19页
        2.3.5 Synthesis of iron oxide nanoparticles第19-20页
        2.3.6 Characterization of Iron Oxide Nanoparticles第20页
        2.3.7 Functionalizing Hydrophobic Nanoparticles第20-21页
        2.3.8 Cancer Cell Enrichment and Detection of NP-Aptamer Cell Uptake第21页
        2.3.9 Cancer Cell Enrichment and Detection Using NP-Aptamer-Antisense Conjugates for GFP Knockdown第21-22页
        2.3.10 Doxorubicin Drug Loading第22页
        2.3.11 MTS Assay第22页
    2.4 Results and Discussion第22-33页
    2.5 Troubles to Overcome第33页
    2.6 Conclusion第33-35页
3. Upconversion Nanoparticles for Mediated Gene Therapy with Aptamer Guidance第35-49页
    3.1 Background第35-37页
    3.2 Design第37-38页
    3.3 Materials and Methods第38-49页
        3.3.1 Materials第38页
        3.3.2 Oligonucleotide Synthesis第38-39页
        3.3.3 Oligonucleotide Purification第39页
        3.3.4 Characterization of NaGdF~4 Nanoparticles第39-41页
        3.3.5 Functionalizing Hydrophobic Nanoparticles第41页
        3.3.6 Cancer Cell Enrichment and Detection Using NP-Aptamer-Antisense Conjugates for GFP Knockdown第41-42页
        3.3.7 Results and Discussion第42-47页
        3.3.8 Troubles to Overcome第47页
        3.3.9 Future Work第47-49页
4. Side by Side Analysis for the Two Nanoparticles第49-56页
    4.1 Relaxivities and MRI第49-52页
    4.2 GFP Knockdown第52-54页
    4.3 MTS Assay第54-56页
5. Environmentally Sensitive Aptamer Probe第56-68页
    5.1 Background第56-58页
    5.2 Design第58-60页
    5.3 Materials and Methods第60-63页
        5.3.1 Materials第60页
        5.3.2 Amine Modified Aptamer第60-61页
        5.3.3 Purifying Amine-Modified Oligonucleotide第61页
        5.3.4 Labeling with Aptamer第61-62页
        5.3.5 Ethanol Precipitating the Labeled Aptamer第62页
        5.3.6 Purification of Labeled Aptamer by HPLC第62页
        5.3.7 Incubation of Aptamer with Human IgE Protein第62-63页
    5.4 Results and Discussion第63-67页
    5.5 Future Work第67-68页
6. References第68-77页
Acknowledgements第77页

论文共77页,点击 下载论文
上一篇:鲍曼不动杆菌耐药性分析及生物膜相关基因的研究
下一篇:耕地集约利用评价研究--以环洞庭湖区为例